Periventricular Leukomalacia Clinical Trial
Official title:
Randomized Controlled Trial of Early Intensive Leg Exercise to Improve Walking in Children With Diplegia From Encephalopathy of Prematurity
This is a randomized controlled trial, comparing 3 months of intensive leg exercise to standard physiotherapy care for the improvement of gross motor function in young children with spastic diplegia.
Children born prematurely are at risk of brain injury that can result in cerebral palsy, most often affecting both legs. Current treatment is largely passive, including leg braces, repeated injection of a paralyzing agent (botulinum toxin) in muscles that are abnormally active, and surgery as deformities occur. Active, physical therapy for weak muscles is infrequent, occurring twice a month or less. Yet, recent work in mammals show that early brain injury can be alleviated by intensive exercise therapy, but only while the animal is very young. Building on our success with early, intensive therapy for children with perinatal stroke, we will apply intensive therapy for the legs in children with cerebral palsy involving both legs. Children (8 mo - 3 yr old) will be randomly assigned to start treatment immediately or delay treatment for 6 months. The delay period controls for improvement without treatment. The children in the Delay Group will have the option to receive the same treatment after the delay period. The therapy will be guided by physical therapists, and centered on play. Measures will be taken before, during and after the delay and treatment periods. Measures will include clinical scores of motor development, proficiency of walking, participation at home, and physiological measures of motor and sensory function. All children will be followed until they turn 4 yr old, to determine if there are long term benefits. The cost-effectiveness of the intervention will be evaluated by a health economist. We anticipate that early intensive exercise will improve mobility, facilitate earlier and better walking, and that the effects will be enduring. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Completed |
NCT00375908 -
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury
|
N/A | |
Active, not recruiting |
NCT00515281 -
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
|
Phase 2/Phase 3 | |
Completed |
NCT03635775 -
Single-session tDCS in Cerebral Palsy
|
N/A | |
Completed |
NCT02342990 -
Telerehabilitation of Working Memory in Children With Periventricular Leukomalacia and Bilateral Cerebral Palsy
|
N/A | |
Active, not recruiting |
NCT04873752 -
A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy
|
Phase 1/Phase 2 | |
Terminated |
NCT00589953 -
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
|
Phase 2 | |
Completed |
NCT00120588 -
Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth
|
Phase 4 | |
Completed |
NCT04077333 -
MISA to NRDS:a Multicenter Study in China
|
N/A | |
Terminated |
NCT00303082 -
Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity
|
Phase 3 | |
Completed |
NCT00413946 -
Does Erythropoietin Improve Outcome in Very Preterm Infants?
|
Phase 2 | |
Completed |
NCT02784821 -
Antibiotic "Dysbiosis" in Preterm Infants
|
Phase 2 | |
Completed |
NCT04535375 -
Sonographic QUantification of Venous Circulation In the Preterm Brain
|
N/A | |
Completed |
NCT00014989 -
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
|
Phase 3 | |
Withdrawn |
NCT03527498 -
Evaluation of Long-term Neurodevelopment in Neonatal Encephalopathy by Infant Treadmill
|
N/A | |
Terminated |
NCT03534466 -
Evaluation of Long-Term Gait Development in Infants With Neonatal Encephalopathy Using Infant Treadmill
|
N/A | |
Recruiting |
NCT05520359 -
Spinal Stimulation and Mobility Devices
|
N/A | |
Completed |
NCT02221219 -
Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury
|
Phase 1/Phase 2 | |
Recruiting |
NCT02814383 -
Prediction of Brain Injury in Premature Infants
|
||
Recruiting |
NCT03110341 -
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
|
Phase 3 |